Ozempic and Your Kidneys: Risks, Benefits & What the Evidence Shows (2026)

The honest answer about Ozempic and your kidneys is that it cuts both ways. In the short term, the main kidney danger is acute kidney injury (AKI) from dehydration — when severe nausea, vomiting, or diarrhea cause you to lose fluid, and the FDA prescribing information notes reports of acute kidney injury and worsening of chronic kidney disease, sometimes requiring dialysis, usually in the setting of those gastrointestinal side effects.^[1] In the long term, the picture flips: the landmark FLOW trial (published in the New England Journal of Medicine in 2024) found that semaglutide reduced major kidney-disease events and slowed the decline in kidney function in people who had type 2 diabetes and chronic kidney disease — a major, genuinely positive finding.^[2] Both things are true at once, and understanding the difference is the whole point of this guide. Ozempic is semaglutide; see our Ozempic drug page and the broader Ozempic side effects guide for the full picture. This is general educational information, not medical advice — your prescriber manages your care.

The short-term risk: acute kidney injury from dehydration

The kidney danger that shows up early on Ozempic is not the drug attacking the kidneys directly — it is dehydration. Semaglutide's most common side effects are gastrointestinal: nausea, vomiting, and diarrhea. When those are severe, they cause volume loss — you lose fluid faster than you replace it — and the kidneys, which depend on adequate blood flow, can be injured when that flow drops. The FDA prescribing information reflects exactly this: it notes reports of acute kidney injury and worsening of chronic kidney disease, some requiring dialysis, in patients who experienced nausea, vomiting, diarrhea, or dehydration on semaglutide.^[1] The consumer drug information on MedlinePlus likewise tells patients to contact their prescriber about severe or persistent gastrointestinal symptoms and signs of dehydration.^[3]

The key word is setting. AKI here is overwhelmingly a downstream consequence of dehydration, not a routine event in someone who is eating, drinking, and tolerating the medication. That is reassuring in one sense — it means the risk is largely preventable by protecting your fluid status — but it also means the risk is real and concentrated in predictable situations: an intense bout of vomiting or diarrhea, a stomach bug layered on top of the drug, or the rough days right after a dose increase when GI symptoms tend to peak.

Who is at higher risk

Some people start from a more vulnerable position, where the same amount of fluid loss is more likely to tip the kidneys into trouble. The risk of dehydration-related acute kidney injury is higher if you:

• Already take diuretics ("water pills"). Diuretics increase fluid loss on their own, so layering severe GI fluid losses on top can compound dehydration quickly.^[1]
• Take ACE inhibitors or ARBs. These common blood-pressure and kidney-protective medications change how the kidney regulates its own blood flow, which can make the kidney more sensitive to a drop in volume during dehydration.^[1]
• Already have chronic kidney disease (CKD). Kidneys with reduced baseline function have less reserve, so the label specifically notes the possibility of worsening chronic kidney disease in this setting.^[1]
• Are older or take several of these medications together. The more overlapping factors — age, baseline kidney impairment, diuretics plus an ACE inhibitor or ARB — the smaller the margin during a bad GI episode.

None of this means people in these groups can't take semaglutide — many do, safely and with benefit. It means the dehydration-prevention steps below matter more for them, and that their prescriber may want closer monitoring of kidney function, especially during dose escalation or any illness.

The long-term benefit: the FLOW trial

Here is the side of the story that surprises people: over the long term, semaglutide has actually shown kidney-protective effects. The pivotal evidence is the FLOW trial, published in the New England Journal of Medicine in 2024. FLOW was a randomized, placebo-controlled trial in adults who had type 2 diabetes and chronic kidney disease — exactly the population most worried about their kidneys — and it tested whether semaglutide could protect them.^[2]

The result was clearly positive. Semaglutide reduced the risk of major kidney-disease events — the trial's composite of outcomes such as kidney failure, a substantial sustained loss of kidney function, and death from kidney or cardiovascular causes — and it slowed the decline in eGFR, the standard measure of how fast kidney function is being lost, compared with placebo.^[2] In plain terms: in the people most at risk, semaglutide didn't just avoid harming the kidneys — it appeared to help preserve them over time. That is a genuinely important finding, and it is part of why GLP-1 medicines are increasingly discussed in the context of organ protection, not only weight and blood sugar.

Putting it together: short-term caution, long-term benefit

So how can semaglutide both risk kidney injury and protect the kidneys? Because the two effects operate on different timescales and through different mechanisms. The short-term risk is indirect and situational — it comes from dehydration during severe GI side effects, not from the drug poisoning the kidney. The long-term benefit is a direct property of the therapy demonstrated over years in a high-risk population. The practical takeaway is not "kidneys good" or "kidneys bad" — it's a sequence:

How to protect your kidneys on Ozempic

Because the short-term risk runs through dehydration, almost all of the protection is about defending your fluid status, especially when GI side effects flare. The following are general, commonly-discussed strategies — all of them are prescriber-directed. Do not change your Ozempic dose, stop a blood-pressure medication, or adjust other drugs on your own.

• Stay hydrated and replace electrolytes. Keep fluids steady through the day, and pay extra attention during any nausea, vomiting, or diarrhea. Adequate hydration is the single most important safeguard against dehydration-related kidney injury.^[1]
• Manage GI side effects early. Don't let nausea, vomiting, or diarrhea run unchecked. Smaller, blander meals, eating slowly, and prescriber-recommended measures can reduce the fluid losses that drive the risk in the first place.^[3]
• Have a "sick day" plan. Ask your prescriber in advance what to do if you become very ill — for example with a stomach bug — because they may advise holding a dose of semaglutide (and sometimes temporarily pausing diuretics, ACE inhibitors, or ARBs) until you can keep fluids down. This is a conversation to have before you're sick, and any such change must come from your clinician.^[1]
• Know your numbers if you're at higher risk. If you have CKD or take a diuretic, ACE inhibitor, or ARB, your prescriber may monitor kidney function more closely, particularly during dose escalation. Keep those appointments.^[1]
• Don't wait out warning signs. Markedly reduced urination, swelling, severe fatigue or confusion, or relentless nausea — especially when dehydrated — are reasons to seek care promptly rather than push through.^[3]

For the full list of what's common versus serious, see Ozempic side effects, and for the medication itself see our Ozempic drug page. A legitimate prescriber titrates you on the label schedule, asks about GI side effects, and — for at-risk patients — keeps an eye on kidney function, which is exactly the monitoring that keeps the short-term risk small while the long-term benefits accrue.